Analyst Reco. Gabather AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:22:02 2024-05-17 am EDT			5-day change	1st Jan Change
1.815 ^SEK	-11.89%		-17.87%	+28.72%

Apr. 10	Gabather AB Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct A Clinical Phase II Study with GT-002	CI
Mar. 18	Gabather Submits Two US Patent Applications for GT-002 Use in Psychiatric Disorders	MT

No results for this search